Reference ID: 4036863
Raynaud’s Phenomenon 5.6 Long-Term Suppression of Growth. 5.7 Visual Disturbance. 5.8 Potential for Gastrointestinal Obstruction. 5.9 Hematologic Monitoring. 6 ADVERSE REACTIONS 6.1. Commonly Observed Adverse Reactions in Double-Blind, Placebo-Controlled Clinical Trials 6.2 Other Adverse Reactions Observed in . CONCERTA Clinical Trials 17
Download Reference ID: 4036863
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
STIHL BG 55, 65, 85, SH 55, 85 Owners Instruction Manual
www.stihlusa.comdisease (Raynaud's phenomenon) or carpal tunnel syndrome. These conditions reduce the hand's ability to feel and regulate temperature, produce numbness and burning sensations and may cause nerve and circulation damage and tissue necrosis. WARNING This STIHL blower is not equipped with an anti-vibration ("AV") system. Other
Stimulant and Related Medications: Use in Adults
www.cms.govvasculopathy, including Raynaud’s phenomenon and the associated signs and symptoms. The Medication Guides have been revised to include this drug safety information as well.[21] Risk of Priapism with Methylphenidate Products In December 2013, the FDA published a Drug Safety Communication to warn that methylphenidate-containing
I-RECOVER | Management Protocol for Long Haul COVID-19 ...
covid19criticalcare.comfront line covid-19 critical care alliance prevention & treatment protocols for covid-19 i-recover 2021.!
STIHL TS 700, 800
www.stihlusa.comdisease (Raynaud's phenomenon) or carpal tunnel syndrome. These conditions reduce the hand's ability to feel and regulate temperature, produce numbness and burning sensations and can cause nerve and circulation damage and tissue necrosis. All factors which contribute to whitefinger disease are not known, but cold weather, smoking and
La sclérodermie - Orphanet
www.orpha.netcalcinose, le phénomène de Raynaud, le dysfonctionnement œsophagien, la sclérodactylie et la télangiectasie. Ces cinq signes ne sont pas forcément tous présents. - La calcinose se caractérise par la formation de petits dépôts de calcium blanchâtres (dé-pôts calciques) sous la peau.